Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Targeting the pain, inflammation and immune (PII) axis: plausible rationale for LLLT

Targeting the pain, inflammation and immune (PII) axis: plausible rationale for LLLT Abstract Low-level laser therapy (LLLT) has been used in many clinical contexts. Although its precise mechanism is unclear, its current use is based predominantly on its non-invasive nature and popular patient acceptance. This review attempts to provide a framework for the clinical disease-disorder states focusing on the etiopathology namely; pain, inflammation and immune response termed the PII axis. Following a brief introduction, the literature on the ability of LLLT to modulate the PII axis in specific disease states is reviewed. The triad of critical parameters for LLLT namely, the dose, the biological context and the mechanism are highlighted. This work suggests that LLLT could be a potent primary interventional modality when used to specifically target the PII axis in clinical disease management. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Photonics & Lasers in Medicine de Gruyter

Targeting the pain, inflammation and immune (PII) axis: plausible rationale for LLLT

Download PDF
14 pages

Loading next page...
 
/lp/de-gruyter/targeting-the-pain-inflammation-and-immune-pii-axis-plausible-ns7503ifDs

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
de Gruyter
Copyright
Copyright © 2012 by the
ISSN
2193-0635
eISSN
2193-0643
DOI
10.1515/plm-2012-0033
Publisher site
See Article on Publisher Site

Abstract

Abstract Low-level laser therapy (LLLT) has been used in many clinical contexts. Although its precise mechanism is unclear, its current use is based predominantly on its non-invasive nature and popular patient acceptance. This review attempts to provide a framework for the clinical disease-disorder states focusing on the etiopathology namely; pain, inflammation and immune response termed the PII axis. Following a brief introduction, the literature on the ability of LLLT to modulate the PII axis in specific disease states is reviewed. The triad of critical parameters for LLLT namely, the dose, the biological context and the mechanism are highlighted. This work suggests that LLLT could be a potent primary interventional modality when used to specifically target the PII axis in clinical disease management.

Journal

Photonics & Lasers in Medicine – de Gruyter

Published: Nov 1, 2012

There are no references for this article.